ArticleFrontiers in oncology2020

Previous Use of Anti-Vascular Endothelial Growth Factor Receptor Agents Decreases Efficacy of Fruquintinib in Metastatic Colorectal Cancer Refractory to Standard Therapies.

Lei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.